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Abstract
Background: Mice deficient in the inhibitory G protein subunit Gai2 spontaneously develop a T helper 1 dominated colitis.
We examined whether a defect in CD4
+FoxP3
+ regulatory T cells (Treg) underpins the pathogenesis of colitis in the Gai2
2/2
(Gai2-deficient) colitis model.
Methodology/Principal Findings: Using flow cytometry, we found that thymus and colonic lamina propria, but not spleen
and mesenteric lymph nodes, of colitic Gai2
2/2 mice contained increased frequencies of Treg, whereas FoxP3 expression
intensity was similar in Gai2
2/2 compared to Gai2
+/2 or Gai2
+/+ wild type (WT) mice. The frequency of CD4
+FoxP3
+ T cells
expressing CD103 was significantly increased in Gai2
2/2 compared to WT mice. Treg in colons from WT mice clustered in
the T cell areas of colonic lymphoid patches (CLP), with relatively few Treg in the lamina propria, as demonstrated by
immunohistochemistry. In Gai2
2/2 mice, CLP were not observed but lamina propria Treg were increased in number and
frequency within the CD4
+ infiltrate, compared to WT mice. Using an in vitro co-culture system and flow cytometric analysis
of cell division we could demonstrate that the in vitro suppressive function of WT and Gai2
2/2 CD4
+FoxP3
+ regulatory T
cells (WT-Treg and KO-Treg) was indistinguishable, but that T effector cells (CD4
+25
2 T cells) from Gai2
2/2 mice were less
readily suppressed than WT effectors (WT-Teff) by Treg from either source. However, neither WT nor Gai2
2/2 Treg was able
to suppress colitis induced by adoptive transfer of Gai2
2/2 effector T cells (KO-Teff) to RAG2
2/2 recipients. The enhanced
inflammatory activity of Gai2
2/2 effectors was accompanied by increased expression of an effector/memory T cell
phenotype and increased cytokine secretion, especially IL-4, IL-6 and IFN-c.
Conclusions: There is an increased frequency of Gai2
2/2 Treg in the colon, and they demonstrate no endogenous
functional defect. However, Gai2
2/2 T effector cells are dramatically less susceptible to suppression in vitro, and in vivo,
despite increased effective numbers of Treg, they cannot prevent disease.
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Introduction
The mucosal immune dysregulation which results in chronic
inflammatory bowel disease (IBD) has been evaluated using several
chemically-induced, T cell transfer and spontaneous mouse
models of colitis. Untreated Gai2
2/2 mice on a 129SvEv
background spontaneously develop colitis [1,2,3]. The inflamma-
tion is restricted to the large intestine, resembling the pathology
seen in human ulcerative colitis (UC) with crypt distortion, loss of
mucin producing goblet cells, and abscess formation together with
erosion and ulcerations of the mucosa [1,2,3].
The development of colitis in the Gai2
2/2 mouse model is
dependent on the presence of an enteric microflora (unpublished
observations) and is characterized by a Th1 CD4
+ T cell response,
with increased production of IFN-c, together with increased levels
of IL-1, IL-6 and TNF-a in inflamed tissue [1,2,4]. The lack of
Gai2 results in functional disorders in epithelial cells [5],
professional antigen-presenting cells [6], B cells [2,4,6] and
CD4
+ T cells [1,3,7,8,9] and points to multiple requirements for
Gai2 in mucosal immune regulation, but the underlying molecular
mechanisms involving Gai2 have not been defined.
Mucosal tolerance to environmental and food antigens is
essential to prevent exacerbated immune reactions that can cause
allergic diseases and chronic inflammation, and it has long been
recognized that the gut is an important site for the induction of
tolerance [10]. Peripheral immune tolerance is mediated by
several mechanisms, including anergy; deletion; ignorance; or
suppression of effector T cell (Teff) function by different
populations of regulatory T cells (Treg) [11]. There are two
subsets of Treg: natural Treg (nTreg), which develop in the
thymus; and inducible Treg (iTreg), which are derived from naı ¨ve
CD4
+ T cells in the periphery. Inducible Treg comprise type 1
regulatory T cells (Tr1), which are induced by IL-10 [12] and T
helper 3 (Th3) cells, which are induced by TGFb [13]. Treg utilize
a variety of mechanisms to suppress the immune response.
Generally, nTreg are believed to suppress by a cell–cell contact-
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mediated cytotoxicity or by cAMP), while their regulatory effects
in vivo are assumed to be mainly cytokine-mediated [14,15].
The development, function, and homeostasis of Treg are
controlled by the forkhead family transcription factor, Foxp3
[16,17,18]. Mutations in the gene encoding Foxp3/FOXP3 have
been identified in both mice and humans [16,19]. Patients with
mutations in FOXP3 develop a severe, fatal systemic autoimmune
disorder, Immune Dysregulation Polyendocrinopathy Enteropathy
X-linked (IPEX) syndrome [19]. Experiments using adoptive
transfer of effector and regulatory T cell populations into
immunodeficient mice indicate a crucial role for Treg in
maintaining mucosal immune homeostasis [20,21], suggesting
that dysfunction of Treg may be a contributory factor in the
pathogenesis of human IBD.
In this study, we address the hypothesis that colitis in Gai2
2/2
mice is a consequence of a qualitative or quantitative defect in
CD4
+FoxP3
+ regulatory T cells (Treg). The data show that
although Treg from Gai2
2/2 mice are functional in vitro, and are
present at enhanced frequency within the CD4
+ infiltrate in colitis,
they are unable to prevent disease caused by endogenously
activated Gai2
2/2 effector T cells, the latter being significantly
more resistant to suppression by either wild type or Gai2
2/2 Treg.
Materials and Methods
Ethics statement
All animal procedures were carried out under local and national
ethical guidelines (Swedish Board of Agriculture) and were
approved by the regional ethical committee, Gothenburg
Administrative Court of Appeal, with the ethical approval ID
79-2008.
Mice
Gai2
2/2 deficient (Gai2
2/2) mice on a pure 129SvEv
background were bred and maintained under specific pathogen-
free conditions in microisolator cages with filtered air at the
Department of Experimental Biomedicine, University of Gothen-
burg. Heterozygous Gai2
+/2 males were bred with heterozygous
females, and the offspring were genotyped by polymerase chain
reaction (PCR) analysis using genomic DNA from the tail.
Homozygous Gai2
2/2 mice on this background develop a lethal
colitis between the age of 5 and 8 weeks. In this study, mice were
euthanized at 4–5 weeks (pre-colitic) or 5–9 weeks (colitic) and the
absence/presence of colitis was confirmed post mortem. The
experiments included both male and female mice as gender
differences in clinical disease or immune parameters have not been
found [7]. Both homozygous wild-type (WT) Gai2
+/+ and
heterozygous (Gai2
+/2) mice were used as controls in the study
(collectively referred to here as ‘‘WT mice’’). RAG2
2/2 mice on a
129SvEv background (a kind gift from F. Powrie, Univ. of Oxford)
were bred homozygous, and were used as recipients in our cell
transfer model.
Media and antibodies
Fetal calf serum (FCS), 2-mercaptoethanol and Triton X-100
were purchased from Sigma-Aldrich (St. Louis, MO). Fixation/
Permeabilization solution was purchased from eBioScience (San
Diego, CA). Calcium and magnesium free HBSS (CMF-HBSS),
HEPES, RPMI 1640 medium, GlutaMAX I and gentamicin were
purchased from Invitrogen-GIBCO (Carlsbad, CA).
Antibodies used were: rat IgG2b anti-mouse CD16/CD32
(2.4G2), rat IgG2a anti-mouse CD4-Pacific Blue (PB) or -FITC
(RM4-5), hamster IgG3 anti-mouse CD3-PE (145-2c11), CD62L
(L-selectin/LECAM-1/Ly-22), CD44 (Pgp-1/H-CAM/Ly-24), rat
IgG1 anti-mouse CD25-APC (PC61), rat IgG2a anti-mouse CD4
(L3T4), rat IgG2a k isotype control, all BD Pharmingen (San Jose,
CA); rat IgG2a isotype control (eBR2a), rat IgG2a anti-mouse
Foxp3-PE or FITC (FJK-16S) (Flow Cytometry) or unconjugated
(Immunohistochemistry), all eBioScience (San Diego, CA); goat
anti-rat IgG Alexa Fluor 488, goat anti-rat IgG Alexa Fluor 568
amplification, all Molecular Probes-Invitrogen (Eugene, OR).
Soluble a-CD3 mAb (10% supernatant from hybridoma 45-2C11)
was produced in-house.
Immunohistochemistry
Mouse colons were removed intact and rolled around a
toothpick with proximal colon on the inside and distal colon on
the outside of the roll, embedded in OCT compound (Tissue-
TekH, Miles Inc., Elkhart, IN), frozen in liquid nitrogen-cooled
isopentane and stored at 280uC. Frozen sections, 6 mm (sectioned
on a Leica CM3050s cryostat (Leica Microsystems, Wetzlar,
Germany)), were fixed in 100% cold acetone for 10 min prior to
H&E or fluorescence staining. For FoxP3/CD4 double labelling,
sections were post fixed in 4% buffered formaldehyde for 5 min
and permeabilized using 0.5% Triton X-100 for 5 min. After
fixation/permeabilization, sections were incubated with rat IgG2a
anti-mouse FoxP3, or with rat IgG2a isotype control, followed by
detection using goat anti-rat IgG Alexa Fluor 568. The samples
were then incubated with rat anti-mouse CD4, followed by goat
anti-rat IgG Alexa Fluor 488. The slides were mounted in 49,6 -
diamidino-2-phenylindole (DAPI)-containing mounting medium
(Molecular Probes-Invitrogen) and visualized with a Zeiss
Axioskop 2 microscope (Carl Zeiss Imaging, Thronwood, NY)
and analyzed by Axiovision 4,5 software (Carl Zeiss Imaging) or
Leica DFC 480 (Leica Microsystems GmbH, Germany). Numbers
of CD4
+ cells and CD4
+FoxP3
+ cells were counted, using Image J
(Image Processing and Analysis in Java, National Institutes of
Health, U.S.A), at 3–5 sites of the mucosa in distal colons from
four colitic Gai2
2/2 mice and 4 WT controls; and at least one
colonic lymphoid patch (CLP) in each of four WT control mice.
Preparation of cell suspensions
Single cell suspensions were prepared from the whole thymus,
spleen or mesenteric lymph nodes (MLN) as previously described
[1,7]. Splenic erythrocytes were lysed with ammonium chloride
and cells were then washed in phosphate-buffered saline (PBS)
containing 1% heat inactivated fetal calf serum (FCS). For
isolation of colonic lamina propria lymphocytes (LPL), dissected
colons were washed free of fecal contents by flushing with saline.
They were then opened longitudinally, washed extensively in
Hank’s Balanced Salt Solution without Calcium and Magnesium
(CMF-HBSS) supplemented with 15 mM HEPES and incubated
for 5615 min at 37uC, in CMF-HBSS containing 5 mM EDTA
to remove epithelial cells and intraepithelial lymphocytes. The
remaining tissue was incubated for 15 min in RPMI 1640
containing 15 mM HEPES and 10% heat inactivated FCS,
followed by three successive 60 min incubations in Liberase/
blendzyme 3 (0.2 Wu ¨nsch units/ml, Roche Applied Science,
Indianapolis, IN) in RPMI 1640 medium+GlutaMAX I contain-
ing 15 mM HEPES and 20% heat inactivated horse serum,
yielding LPLs.
Flow cytometry
Single cell suspensions of 1610
6 cells/30 ml were incubated on
ice for 10 min with unconjugated anti-CD16/CD32 and then for
30 min with: anti-CD4-PB or -FITC; anti-CD3e-PE; anti-CD25-
APC; and anti-Foxp3-PE or -FITC.
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Fixation/Permeabilization solution. Cells were then acquired on a
BD LSRII flow cytometer (BD Biosciences, San Jose, CA), and the
data analyzed using the Flow-Jo software (Tree Star Inc., San
Carlos, CA).
Cell fractionation
Splenic CD4
+ cells were partially purified by negative selection
on AutoMACS (Miltenyi Biotec, Bergisch Gladbach, Germany),
following the manufacturer’s instructions, using the mouse CD4
+
T cell isolation kit (Miltenyi Biotec). Cells were then labeled with
fluorochrome-conjugated CD4-PB, CD25-APC, CD3e-PE in PBS
supplemented with 2% FCS and 2 mM EDTA, washed and
subsequently sorted into CD25
+ and CD25
2 subpopulations using
a FACSAriaH (BD Biosciences). Purity of the sorted cells
(CD3
+CD4
+CD25
+ or CD3
+CD4
+CD25
2) ranged from 95% to
98%. The CD25
+ and CD25
2 populations contained 89.366.9%
(n=9) and 6.361.8% (n=9) (Gai2
2/2 mice) or 91,066,0%
(n=11) and 4,361.4% (n=6) (WT mice) FoxP3
+ lymphocytes,
respectively.
Macroscopic scoring of colitis
Colonic pathology was macroscopically scored in a blinded
fashion by two independent observers and graded for the following
parameters: thickness (0–2), stiffness (0–3), edema (0–3) and visible
ulcerations (0–1), with a total maximum score of 9 [22].
Adoptive transfer
Freshly sorted splenic CD4
+CD25
+ (Treg) and CD4
+CD25
2
cells (Teff), either 4610
5 Teff only, or co-transferred with 1610
5
Treg, from colitic Gai2
2/2 and WT mice were adoptively
transferred into 129SvEv RAG2
2/2 mice by i.p. injection.
RAG2
2/2 mice on this background are resistant to colitis
induction by WT effector T cells in the absence of H hepaticus
infection [23].
Analysis of cell division
Analysis of cell division by dye dilution was performed using a
Vybrant CFDA SE cell tracer kit (CFSE) (Molecular Probes-
Invitrogen). Effector T cells were washed twice with cold PBS,
resuspended in 1 ml 5 mM CFSE solution/10
7 cells, and
incubated for 8 min at room temperature in the dark. Staining
was quenched by adding an equal volume of FCS. Cells were then
washed twice with complete culture medium and used in the
suppression assay. The calculation of percent cell division of Teff
within the Teff:Treg co-cultures was performed using FlowJo
software (Tree Star Inc., San Carlos, CA). The percentage of the
CFSE-labelled Teff cells of the original sample which had divided
are denoted as ‘‘Cell division %’’ in the graph. I.e., if all the Teff in
the starting population have divided, the Cell division %=100%.
Table 1. Frequency of FoxP3
+T cells in CD4
+, CD4
+CD25
+and
CD8
+ subpopulations from mesenteric lymph nodes (MLN), as
determined by flow cytometry.
Mean % ± SD
of FoxP3
+ Range
CD4
+ early colitic mice n=7 10.762.5 (7.34–13.3)
control mice { n=7 9.061.0 (7.84–10.2)
colitic mice n=7 11.461.6 (8.84–12.9)
control mice {{ n=7 9.161.4 (7.76–11.9)
CD4
+CD25
+ early colitic mice n=7 81.068.7 (71.1–94.6)
control mice { n=7 82.0611.9 (66.0–95.1)
colitic mice n=7 79.265.7 (73.2–87.8)
control mice {{ n=7 91.262.2 (88.8–93.4)
CD8
+ early colitic mice n=7 1.661.4 (0.29–3.73)
control mice { n=7 1.261.0 (0.29–2.46)
colitic mice n=7 0.660.3 (0.26–0.96)
control mice {{ n=7 0.460.2 (0.29–0.75)
{: 4–6 weeks old mice,
{{: 7–9 weeks old mice.
doi:10.1371/journal.pone.0025073.t001
Figure 1. Frequency and intensity of expression of FoxP3 in
CD4
+ T cells in central, peripheral and mucosal lymphoid
tissue. A. Frequencies of FoxP3
+ cells in gated CD4
+ T lymphocytes in
colitic Gai2
2/2 mice were compared to age-matched control mice,
(n$6 in each group) as determined by FACS analysis. Each symbol
represents one mouse and the mean of each group is indicated by a
line. Results are shown from at least three independent experiments,
where ***=p#0.001. B. Intensity of FoxP3 expression, measured as
median fluorescence intensity (MFI) of gated CD4
+FoxP3
+ lymphocytes.
Results are shown as mean values 6 SD of n=4 to 6 mice per group,
pooled from at least three independent experiments.
doi:10.1371/journal.pone.0025073.g001
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Sorted splenic CD4
+CD25
2 cells (Teff), 5610
4 cells per well,
stained with CFSE, from colitic Gai2
2/2 or WT mice were
incubated with CD4
+CD25
+ putative Treg from colitic Gai2
2/2
or WT mice at Teff:Treg ratios of 2:1, 4:1, 8:1 or Teff alone in 96-
well round-bottom plates for 72 h at 37uCi n5 %C O 2 in the
presence of soluble a-CD3 mAb in Basal Iscove complete medium
containing 10% heat-inactivated fetal calf serum, 50 mM2 -
mercaptoethanol, 1 mM L-glutamine, and 50 mg/ml gentamicin.
Irradiated (25 Gy Cesium-137) T cell-depleted spleen cells from
WT mice were used as accessory cells at 2610
5 cells per well.
Cytokine measurements in supernatants
Cytokine concentrations in supernatants from the suppression
assays were measured using a cytometric bead array (CBA) kit,
mouse Th1/Th2/Th17 cytokine kit (BD Pharmingen); according
to the manufacturer’s instructions. Cytokine levels were quanti-
tated using calibrated standards of each cytokine and analyzed by
the CBA software.
Statistical analysis
The Mann-Whitney non-parametric test for unpaired data, the
Student t-test or one-way ANOVA (Tukey’s Multiple Comparison
Test) were used for comparison between groups. Differences were
considered statistically significant at p,0.05.
Results
FoxP3 expression is restricted to CD4
+ T cells
The localization of FoxP3 expression within T cell subpopula-
tions in Gai2
2/2 and WT mice was analyzed, using mesenteric
lymph node (MLN) cells. As illustrated in Table 1, FoxP3
+ cells
Figure 2. Immunohistochemical analysis of distribution of CD4
+FoxP3
+ cells in colonic tissues. A, B, E, F=colon from WT mice; C,
D=colon from Gai2
2/2 mice with colitis. Tissues were double stained for CD4 and FoxP3. Images shown are double positive (DP) CD4
+ (green)
FoxP3
+ (red) (A, C, E) (where DP cells appear as yellow), or single positive (SP) FoxP3 (grey) (B, D, F); In WT colonic mucosa (A, B), CD4
+ T cells were few
in number and were mostly confined to the basal lamina propria. In colitis (C, D), CD4
+ T cells infiltrated the entire lamina propria and included many
DP cells. Within colonic lymphoid patches (CLP) of WT mice (E, F), interfollicular T cell areas contained many DP CD4
+FoxP3
+ cells (compare to paucity
of DP cells in normal mucosa to left and right). G–J, controls: G, CD4/FoxP3; H, CD4/FoxP3 isotype control; I, CD4 isotype control/FoxP3; J, CD4 isotype
control/FoxP3 isotype control. Original magnifications: 620. K. Absolute numbers of CD4
+ cells and CD4
+FoxP3
+ cells were counted at 3–5 sites of
mucosa in distal colons from 4 colitic Gai2
2/2 mice and 4 WT control mice; at least one Colonic Lymphoid Patches (CLP) was counted in 4 WT control
mice. ‘‘Upper’’ and ‘‘lower’’ lamina propria were defined as above crypt bases and between crypt base and muscularis mucosa, respectively. L.
Frequency of FoxP3
+ cells within the CD4
+ population, as calculated from the results in K. Results are shown as mean values 6 SEM of n=4 mice per
group, where *=p#0.05, **=p#0.01 and ***=p#0.001.
doi:10.1371/journal.pone.0025073.g002
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+ T cell population in the MLN in both
precolitic and colitic mice, with 80 to 90% residing in the
CD4
+CD25
+ T cell population. The CD8
+ T cell population had
almost no expression of CD25 (,1% positive cells, data not
shown) and Foxp3 expression was detected on less than 2% of
CD8
+ T cells [Table 1].
Frequency of FoxP3
+ lymphocytes in central, peripheral
and gut-associated lymphoid tissues
We and others have reported that precolitic Gai2
2/2 mice
develop thymic atrophy, a significant decrease in the number of
thymocytes, and a higher frequency of mature thymocytes,
compared to WT mice [7,24]. As FoxP3 expression is restricted
to CD4
+ mature single positive thymocytes, we examined the
frequencies of CD4
+FoxP3
+ thymocytes in Gai2
2/2 compared to
WT mice. Gai2
2/2 CD4
+ mature thymocytes contained a
significantly higher frequency of FoxP3
+ cells compared to WT
thymocytes (p,0.01) (Fig. 1A). In contrast, there were no
significant differences in the frequency of splenic and MLN
CD4
+FoxP3
+ T cells between colitic Gai2
2/2 and age-matched
WT mice. The frequency of CD4
+FoxP3
+ T cells was, however,
significantly higher (p,0.001) in the colonic lamina propria (LP) of
colitic Gai2
2/2 mice, compared to the healthy colon of WT
controls. In addition, we also analyzed the intensity of expression
of FoxP3 within CD4
+FoxP3
+ cells in the thymus, spleen, MLN,
and colonic lamina propria, measured as median fluorescence
intensity (MFI). No statistically significant differences were found
in these four lymphoid tissues between colitic Gai2
2/2 and age-
matched WT mice, (Fig. 1B). These data indicate that the
spontaneous chronic inflammation in Gai2
2/2 mice cannot be
explained by a simple quantitative reduction of Treg within total
colonic tissues.
However, as it is likely that the function of Treg is related to
their distribution within tissues in relation to effector T cells, we
further examined their tissue distribution in colonic tissues of WT
and colitic Gai2
2/2 mice, by immunohistochemistry. In the
lamina propria of WT mice, CD4
+ T cells were sparse, mostly
restricted in the tissue to the level of the crypt bases, and contained
few FoxP3
+ cells (1–4%, Fig. 2A–B, K–L). In colonic lymphoid
patches (CLP) of WT mice, large numbers of CD4
+FoxP3
+ Treg
were observed, restricted to the interfollicular T cell areas (Fig. 2E–
F), comprising 10–15% of the total CD4
+ T cells in this tissue
(Fig. 2L). In colitic Gai2
2/2 mice, the distribution was quite
different. In the inflamed colon, no discrete CLP with associated
clustered CD4
+FoxP3
+ Treg were observed. Instead, the colonic
lamina propria, particularly above the level of crypt bases, was
heavily infiltrated by CD4
+ cells – a 106increase over equivalent
WT tissues (Fig. 2A–J, K). A significant number of these CD4
+
infiltrating cells expressed FoxP3 (Fig. 2K), with a 10–206
increase in the number of CD4
+FoxP3
+ cells in the basal and
upper mucosa, respectively. Similar to the flow cytometric
analysis, their frequency in the upper lamina propria were
increased 2–36 compared to CD4
+ cells in WT colon (Fig. 2L).
Thus, the hyperplastic mucosa in established colitis was heavily
infiltrated by a ten-fold increase in CD4
+ T cells, and the
proportion of FoxP3
+ cells rose by two- to three-fold. However,
this was preceded by a loss of CLP, which, in the WT colon,
contain the major proportion of Treg.
Figure 3. Expression of integrin aE (CD103) onCD4
+CD25
+FoxP3
+
Treg cells from central, peripheral and mucosal lymphoid tissue.
Frequencies of CD4
+CD25
+FoxP3
+ Treg cells in thymus, spleen,
mesenteric lymph nodes (MLN) and colon from 5 to 8 weeks old colitic
Gai2
2/2 mice and age-matched WT littermates. (n$6 in each group),
expressing CD103 were determined by FACS analysis. Gates were set on
the CD4
+CD25
+FoxP3
+ subpopulation of lymphocytes. Each symbol
represents one mouse and the mean is indicated by a line. Results
pooled from at least three independent experiments, where
**=p#0.01 and ***=p#0.001.
doi:10.1371/journal.pone.0025073.g003
Figure 4. Increased frequencies of CD62L
+ and CD44
+ effector T
cells in spleens of Gai2
2/2 mice. A. Frequencies of CD62L
+ cells in
gated CD4
+CD25
2 splenocytes in colitic Gai2
2/2 mice were determined
by FACS analysis and compared to age-matched control mice, (n=5 in
each group) B. Expression of CD44
+ cells in gated CD4
+CD25
2
splenocytes in early colitic, colitic Gai2
2/2 mice and age-matched
control mice, (n=5–6 in each group). Each symbol represents one
mouse and the mean of each group is indicated by a line. Results are
shown from at least three independent experiments, where *=p#0.05,
**=p#0.01 and ***=p#0.001.
doi:10.1371/journal.pone.0025073.g004
Regulatory T Cells in Gai2
2/2 Colitis
PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e25073High frequencies of CD103-expressing Treg in colitic
Gai2
2/2 mice
Integrin aE(CD103)ß7 contributes to mucosa specific retention
of T cells and other cells within epithelia by binding to E-cadherin
[25,26]. In addition, CD103 has a possible accessory function for
activation of intraepithelial lymphocytes. It has been reported that
CD103 is a marker for activated Treg [27] We therefore
investigated the frequency of Treg with CD103 expression in
primary, secondary and gut-associated lymphoid tissues in
Gai2
2/2 mice. As shown in Fig. 3, the frequency of CD4
+FoxP3
+
T cells expressing CD103 was significantly increased in Gai2
2/2
compared to WT mice in all four tissues studied: thymus, spleen,
MLN, and colonic lamina propria.
Treg from colitic Gai2
2/2 mice fail to protect against
colitis in a transfer model
Our group and others have reported that CD4
+ T cells from
Gai2
2/2 mice undergo altered development and amplified
responses to TCR ligation [7,8]. The increase in frequency of
Treg among total CD4
+ T cells in the thymus and in the inflamed
colon of Gai2
2/2 mice, compared to WT mice prompted us to
investigate the functional activity of the Treg in vivo and in vitro.
CD4
+CD25
2 effector T cells from colitic Gai2
2/2 mice (KO-
Teff), or CD4
+CD25
2 effector T cells from WT mice (WT-Teff)
were transferred with or without CD4
+CD25
+ Treg from
Gai2
2/2 mice with colitis (KO-Treg) or WT mice (WT-Treg) at
a 4:1 Teff:Treg ratio into RAG2
2/2 recipients. Analysis of the
activation phenotype of these transferred CD4
+CD25
2 cells
showed that those derived from colitic Gai2
2/2 donor spleens
contained a significantly higher proportion of cells with a
CD4
+CD44
+CD62L
2 effector memory phenotype than those
derived from WT spleens. Interestingly, the data also show that
even in mice of three weeks of age, before the development of
colitic symptoms, splenic CD4
+ T cells contain significantly higher
proportions of effector memory cells (Fig. 4). Five to seven weeks
after T cell transfer, mice receiving WT-Teff cells did not develop
disease, irrespective of the presence or absence of Treg from either
donor. These mice were observed up to 15 or 29 weeks after
transfer and did not develop colitis within this time frame (Fig. 5).
This is consistent with previous studies demonstrating that, in
contrast to the SCID or RAG transfer models on backgrounds
other than 129SvEv, in which naı ¨ve wild type CD45RB
hi T cells
induce colitis upon transfer [21], RAG
2/2 mice on a 129SvEv
background, are resistant to colitis induction by wild type cells in
the absence of H. hepaticus infection [23].
However, the majority of mice (6/8) receiving KO-Teff cells
alone in two separate experiments developed clinical signs of disease
(Fig. 5). Co-transfer of KO-Treg or WT-Treg at a 4:1 Teff:Treg
ratio at 4610
5 had little effect on induction of pathology (5/6 and
4/4, respectively, developing colitis). Thus, the KO-Teff cells were
highly pathogenic and the pathology induced was unaffected by co-
transfer of Treg from either WT or Gai2
2/2 mice.
Treg from Gai2
2/2 mice are fully functional in vitro
The apparent insufficient regulatory function demonstrated in
the in vivo cell transfer model of colitis raises questions regarding
the inherent function of the Treg population in the Gai2-deficient
immune system. It has been shown that co-culture of CD4
+CD25
+
Treg with CD4
+CD25
2 effector T cells (Teff) from wild-type mice
results in inhibition of the proliferative response of CD4
+CD25
2
effectors [28]. We therefore established an in vitro suppression
assay with mixed combinations of Treg and Teff from Gai2
2/2
and WT mice at different ratios. Regulation of these Teff
responses were analyzed in Teff:Treg co-cultures by cell cycle
analysis, using CFSE labeling (Fig. 6). It is apparent from the cell
division data (Fig. 6A, B, D) that Treg from both WT (WT-Treg)
and Gai2
2/2 mice (KO-Treg) were able to suppress proliferation
of both WT-Teff and KO-Teff, with the former being more
readily suppressed (even at 8:1) than KO-Teff which were
suppressed less readily; (at a 4:1 ratio) (Fig. 6A–B). Thus, the in
vitro suppressive functions of the Treg populations from the two
strains of mice were equivalent. However, this again highlights
that KO-Teff were more responsive to signaling through CD3,
probably reflecting their pathogenic potential. This was confirmed
by comparison of proliferation of the Teff populations alone,
measured by CFSE cell cycle analysis (Fig. 6C), demonstrating
significantly higher percentages of WT Teff undergoing cell
division compared to KO Teff.
Finally, an assessment of Teff cytokines produced in these
cultures was made. Supernatants of anti-CD3-activated WT Teff
contained relatively low levels of IL-2, IL-4, IL-6, or IFN-c and it
was not possible to define any significant effects on cytokine levels
Figure 5. Treg from colitic Gai2
2/2 mice fail to protect against colitis in a transfer model. Freshly isolated and sorted donor splenic
CD4
+CD25
2 Teff cells from colitic Gai2
2/2 mice (KO-Teff) or CD4
+CD25
2 effector T cells from WT mice (WT-Teff) were transferred with or without
splenic CD4
+CD25
+ Treg from Gai2
2/2 mice with colitis (KO-Treg) or WT CD4
+CD25
+ Treg (WT-Treg) at a 4:1 (Teff:Treg) ratio into RAG2
2/2 recipients
by i.p. injection. The results are based on three separate experiments.
doi:10.1371/journal.pone.0025073.g005
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significantly higher levels of cytokines were measured in
supernatants of cultures containing activated splenic KO-Teff
compared to WT-Teff: 2–3-fold higher for IL-2; 20–60-fold higher
for IL-4; 10–20-fold higher for IL-6; and up to 130-fold higher for
IFN-c (Fig. 7). It was not possible to define any significant
reductions in effector cytokines attributable to addition of Treg to
the co-cultures, although a trend towards reduced cytokine
production with increasing amounts of Treg in the cultures was
noticed. The cytokines IL-10, IL-17 and TNF-a were below the
detection limit of our assay.
Discussion
Both nTreg and iTreg play a critical role in maintenance of
peripheral tolerance by suppressing potential autoimmune re-
sponses, while simultaneously regulating inflammatory responses
to microbes. Our experiments show that FoxP3-expressing Treg in
Gai2
2/2 mice are restricted to the CD4
+ subpopulation and that
these CD4
+FoxP3
+ T cells are found in higher frequencies in the
thymus and colon of colitic Gai2
2/2 mice.
The high frequency of CD4
+FoxP3
+ thymocytes is consistent
with the Gai2 deficient mice having abnormal thymocyte
Figure 6. Treg from Gai2
2/2 mice are fully functional in vitro, but KO-Teff are less readily suppressed than WT-Teff. CD4
+CD25
2
effector T cells (Teff) and CD4
+CD25
+ regulatory T cells (Treg) were sorted from the spleen of 5 to 8 weeks old colitic Gai2
2/2 mice and from age-
matched WT littermates, respectively. These effector and regulator cells were mixed at various ratios and in different combinations. CD4
+CD25
2 Teff
cells were pre-stained with CFSE before being added to co-cultures. A–B. In the suppression assay, Gai2
2/2 Treg (KO-Treg) or WT Treg (WT-Treg) were
added at the indicated ratios with either Gai2
2/2 Teff (KO-Teff) or WT Teff (WT-Teff) (5610
4 cells per well). The mixtures of cell populations were co-
cultured with irradiated T cell depleted splenocytes from WT mice as accessory cells (2610
5 cells) and soluble a-CD3 mAb for 72 hours. Means 6 SEM
of cell divisions in the suppression assay from FACS analysis is shown. The results presented are from 4 independent experiments, where **=p#0.01
and ***=p#0.001. C. Means 6 SEM of cell divisions of CFSE WT-Teff and KO-Teff from the wells with Teff only, was analyzed by FACS analysis. The
results are based on 4 independent experiments, where ***=p#0.001. D. Representative histograms showing the division of CFSE labeled cells in the
absence or presence of KO-Treg or WT-Treg.
doi:10.1371/journal.pone.0025073.g006
Figure 7. Cytokine production in the suppression assay co-cultures. Supernatants were harvested after 48 hours and assayed for IL-2, IL-4,
IL-6 and IFN-c by CBA analysis. Means 6 SEM of cytokine levels from the collected supernatants in two of the triplicate wells are shown. Results
presented are from 3 independent experiments, where **=p#0.01 and ***=p#0.001.
doi:10.1371/journal.pone.0025073.g007
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aberrant development of CD4
+CD25
+ T regulatory cells [24]. No
differences in intensity of FoxP3 expression by CD4
+ T cells were
found in the thymus, spleen, MLN and colonic lamina propria of
colitic Gai2
2/2 mice and age-matched controls, indicating that
the phenotype is consistent in both groups.
In the colon, the proportion of isolated CD4
+cellswhich expressed
FoxP3 increased 2–3-fold, compared to WT mice. This might be
expected if these putative Treg are migrating into an established site
of inflammation in an attempt to restore homeostasis, a phenomenon
that has also been observed in rheumatoid arthritis patients [29].
However,ithasbeensuggestedthatTregaregeneratedwithinspecial
DC-containing structures within the colon in response to infiltration
by pathogenic CD4
+ T cells [30], implying either a structural
reservoir of Treg precursors within the colon, or a colonic organized
lymphoid structure in which Treg may be generated via DC
interactions. To examine structural implications, we derived
distribution data using immunohistochemistry. These data show that
in the WT mice, the overwhelming majority of colonic FoxP3
+ Treg,
are indeed associated with organized CLP (and isolated lymphoid
follicles (ILF)) structures. In accordance with our previous demon-
stration of regression of Peyer’s patches in Gai2
2/2 mice prior to
colitis [2], CLP and ILF were not observed in inflamed Gai2
2/2
colons but the numbers of lamina propria CD4
+FoxP3
+ cells
increased in inflammation, with their frequency within the total
CD4
+ population increasing, based on both flow cytometry and
immunohistochemistry data. We speculate that CLP represent the
WT equivalent of the minimal DC structures seen in the RAG2
2/2
transfer model [30] and that they may constitute reservoirs in which
Treg either accumulate and/or are generated, although this requires
further investigation. Regardless of this interpretation, CD4
+ cells
with a Treg phenotype clearly accumulate in significantly increased
frequency within the inflamed colonic mucosa.
It is possible that the higher frequency of FoxP3
+ cells in the
colonic lamina propria of colitic Gai2
2/2 mice may be a
consequence of ongoing inflammation, as there was no significant
difference in the frequency of CD4
+FoxP3
+ T cells at other
peripheral sites, such as spleen and MLN, between Gai2
2/2 and
WT mice. These findings concur with reports from human disease
- in patients with active IBD, the number of FoxP3
+ cells in the
affected intestinal mucosa correlates with disease activity [31,32].
Our data show that CD4
+FoxP3
+ Treg, in both central and
peripheral lymphoid tissue in colitic Ga ´i2
2/2 mice have a
substantially higher frequency of cells expressing CD103, com-
pared to controls. CD103 have been reported to be an activation
marker for Treg [33]. The CD4
+FoxP3
+CD103
+ subset expresses
CTLA-4; suppresses T cell proliferation in vitro; and protects mice
from colitis in the severe combined immunodeficient (SCID)
transfer model in vivo [33]. Integrin aE(CD103)b7 can therefore be
regarded as a marker for activated regulatory T cells, including
those operating at the mucosal barrier. It is possible that in the
steady state, Treg efficiently home to lymph nodes, expand and
accumulate where cognate antigens are present. This basal level of
activity prevents priming of autoreactive T cells and maintains
immune homeostasis. However, when this first line of protection
fails and barrier breakdown, tissue destruction and inflammation
occur, changes in the local microenvironment enable further
activation of T cells into Treg with high expression of CD103,
allowing their traffic to affected tissues [34].
Wehave shown that Treg from colitic Gai2
2/2 mice are as potent
as WT Treg in inhibiting the proliferative response of both WT-Teff
and KO-Teff following polyclonal TCR-mediated stimulation invitro,
although KO-Teff were less inhibited by either Treg population
compared to WT-Teff. The crucial finding of our experiments is that
Gai2
2/2 Treg are fully functional and there is no endogenous Gai2-
related defect. Nonetheless, these apparently potent Gai2
2/2 Treg,
paradoxically, were only partially protective against colitis in the
RAG2
2/2 transfer model. However, the protective effect of
Gai2
2/2 Treg in vivo was comparable to WT Treg. On the basis
of the in vitro and in vivo data, we argue that the dysregulated immune
activity in this model is a product of heightened effector cell activity,
and not of reduced Treg function, within the colitic lesion.
Our present and previous data by others clearly demonstrate
that T effectors from Gai2
2/2 mice are more pro-inflammatory
[8]. This is presumably a reflection of the phenotype of the cells we
have used as effectors. The Ga ´i2
2/2 Teff population comprised
many more cells with a CD4
+CD62L
2 CD44
+ effector memory
phenotype than WT Teff, which are more easily activated to
proliferate and less susceptible to regulation by Treg. In addition,
IL-6, one of the proinflammatory cytokines secreted at high levels
by KO-Teff in this study, has been shown to enhance the
resistance of T effector cells to the suppressive effects of Tregs
[35,36]. With regard to this possibility, administration of IL-6R
mAb to SCID mice, after transfer of CD45RB
high T cells, confers
protection from colitis [37], and IL-6–deficient mice have been
shown to be less susceptible to colitis [38]. Finally, cells with this
phenotype can actively suppress the induction of iTreg by cell
contact and secreted factor-mediated mechanisms [39]. Even in
young mice, before the age of onset of frank colitis, Ga ´i2
2/2
CD4
+ T cells are pushed towards this phenotype. It seems likely,
then, that the Ga ´i2
2/2 deletion drives the differentiation of CD4
+
T cells towards this easily activated, not readily regulated, effector
memory phenotype, which proliferate to bacterial antigens in the
Ga ´i2
2/2 colon with a potentially defective epithelial barrier [5],
and actively suppress the induction of appropriate numbers of
inducible regulatory T cells [39]. In addition, defective chemokine
receptor signaling within the Gai2
2/2 environment may reduce
the infiltration of effective numbers of Treg.
In conclusion, Gai2
2/2 Treg that are functionally active in vitro
are enriched in the inflamed colon in Gai2
2/2 mice, but are unable
to regulate the highly potent Gai2
2/2 effector T cells, which we
demonstrated to be significantly more resistant to suppression by
either WT or Gai2
2/2 Treg, compared to WT effector T cells.
Further studies are in progress to investigate the relative kinetics of
mucosal Teff and Treg infiltration during pathogenesis.
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